rennie extra chewable tablets
bayer plc - calcium carbonate; alginic acid; magnesium carbonate heavy - chewable tablet - 625mg ; 150mg ; 73.5mg
tolfenamic acid 200mg tablets
galen ltd - tolfenamic acid - oral tablet - 200mg
tolfenamic acid 200mg tablets
a a h pharmaceuticals ltd - tolfenamic acid - oral tablet - 200mg
tolfenamic acid 200mg tablets
alliance healthcare (distribution) ltd - tolfenamic acid - oral tablet - 200mg
tolfenamic acid 200mg tablets
de pharmaceuticals - tolfenamic acid - oral tablet - 200mg
neutraflux tablets chewable tablet
api’s: alginic acid magnesium hydroxide dried - chewable tablet - each chewable tablet contains: alginic acid bp - combinations
phexxi- lactic acid, l-, citric acid monohydrate, and potassium bitartrate gel
evofem, inc. - lactic acid, l- (unii: f9s9ffu82n) (lactic acid, l- - unii:f9s9ffu82n), citric acid monohydrate (unii: 2968phw8qp) (anhydrous citric acid - unii:xf417d3psl), potassium bitartrate (unii: npt6p8p3uu) (tartaric acid - unii:w4888i119h) - phexxi is indicated for the prevention of pregnancy in females of reproductive potential for use as an on-demand method of contraception. limitations of use phexxi is not effective for the prevention of pregnancy when administered after intercourse [see dosage and administration (2.1)]. risk summary there is no use for phexxi in pregnancy; therefore, discontinue phexxi during pregnancy. there are no data with the use of phexxi in pregnant women or animals. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4 percent and 15 to 20 percent, respectively. risk summary there are no data on the presence of lactic acid, citric acid, and potassium bitartrate or their metabolites in human milk, the effects on the breastfed infant, or the effects on milk production. the safety and effectiveness of phexxi have been established in females of reproductive potential. efficacy is expected to be the same for post-menarchal females
rennie duo 300/1250/147 %v/v tablets chewable
bayer plc - alginic acid calcium carbonate magnesium carbonate - tablets chewable - 300/1250/147 %v/v
gaviscon 500/25/100 milligram tablets chewable
reckitt benckiser ireland ltd - alginic acid magnesium trisilicate aluminium hydroxide gel, dried sodium bicarbonate - tablets chewable - 500/25/100 milligram
gaviscon 250 milligram tablets chewable
reckitt benckiser ireland ltd - alginic acid sodium bicarbonate aluminium hydroxide dried magnesium trisilicate - tablets chewable - milligram